Results of the Phase I clinical trial, presented at the bi-annual Contrast Media Research symposium in Oslo, Norway, conclude that this novel macrocyclic manganese-based contrast agent was well ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a neurotechnology company developing disease-modifying therapies for neurodegenerative diseases, announced today publication of MRI imaging ...

Magnetic Resonance Imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated for its non-ionizing and non-invasive nature. With nearly 40% of MRI procedures requiring contrast ...

Bayer (OTCPK:BAYRY) said that phase 3 data on its experimental MRI contrast agent gadoquatrane met primary and secondary endpoints in phase 3 trials. The QUANTI studies examined gadoquatrane at a ...

Magnetic resonance imaging (MRI) is widely recognized for its role as a powerful diagnostic tool, producing detailed images of the human body. However, advancements are extending its utility far ...

Structural and functional pulmonary MRI measurements may predict future pulmonary exacerbations among individuals with cystic fibrosis.

ISMI offers a radiologist-led Full-Body MRI in Montreal to identify life-saving findings, detect health risks, and support timely decisions. Whole-body MRI can reveal life-altering findings but may ...